Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
Clinical trial NCT01894243 · COMPLETED
Trial details
- NCT number
- NCT01894243
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-13
- Primary completion
- 2016-11-29
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.